Form 4: Centessa Pharmaceuticals Executive Iqbal Hussain Reports Share Sale and Option Exercise

Iqbal Hussain, General Counsel of Centessa Pharmaceuticals, reports the exercise of share options and subsequent sale of shares under a pre-arranged trading plan.

Summary

• On March 17, 2025, Iqbal Hussain, General Counsel of Centessa Pharmaceuticals, exercised options to acquire 6,000 ordinary shares at a price of $5.84 per share.
• Simultaneously, Hussain sold 6,000 ordinary shares at a weighted average price of $16.4495 per share, with individual sales ranging from $16.19 to $17.07.
• These transactions were executed under a Rule 10b5-1 trading plan adopted on September 14, 2024.
• Following these transactions, Hussain directly owns 105,386 ordinary shares and indirectly owns 5,500 ordinary shares through a spouse.
• Hussain also holds options for 309,559 ordinary shares.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reports routine transactions by an officer under a pre-arranged trading plan. There is no indication of positive or negative implications for the company's performance.

Industry Context

Form 4 filings are standard practice for reporting insider transactions and provide transparency to the market regarding the buying and selling activities of company executives and directors.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership by a company officer.

Key Dates

Keywords

Centessa Pharmaceuticals, CNTA, Iqbal Hussain, Form 4, Share Sale, Option Exercise, 10b5-1 Trading Plan, General Counsel